top of page
Learn more home link
We attack neurodegeneration by reducing neurotoxic proteins and therefore improving AXONAL TRANSPORT.
We enhance the FLOW of information along the Information highway of nerve cell.
WE ARE DEVELOPING DRUGS FOR ALZHEIMER’S DISEASE, PARKINSON’S DISEASE, AND OTHER NEURODEGENERATIVE DISORDERS
Our novel approach to addressing chronic and acute neurodegeneration offers new hope in the fight against the largest unmet need of an aging population
Americans with Alzheimer's Disease
Increase in Alzheimer diagnoses by 2060
Failed drug development attempts since 1998
Neurotoxic proteins reduce axonal transport and cause a
Impaired axonal transport lowers levels of neurotransmitters and neurotrophic proteins leading to nerve cell death.
We Are Working to
the Toxic Cascade
Plaques, tangles, and Lewy bodies represent the end stage of neurodegeneration. The disease STARTS with impaired axonal transport caused by high levels of neurotoxic proteins.
bottom of page